Imagery Rescripting for Obsessive Compulsive Disorder and Body Dysmorphic Disorder: a Multiple-Baseline Single-Case Experimental Design.

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this multiple baseline case series study is to test the effect of imagery rescripting (ImRs) in Obsessive Compulsive Disorder (OCD) and Body Dysmorphic Disorder (BDD). Primary objective :The course of schema or core beliefs and change in OCD and BDD. To investigate the effectiveness of imagery rescripting on factors presumed to underlie the disorder, according to schema theory, and on OCD and BDD symptoms. Secondary objective: The change in OCD and BDD symptoms (full questionnaire), schemata and modes, core emotions, mood, affect and obtrusiveness of intrusion. Other objectives are research into the working mechanisms of imagery rescripting by collecting qualitative data from patients and their practitioner in a qualitative interview. For this study, a multiple-baseline single-case experimental design (SCED) is used testing different outcome variables in 18 OCD patients and 18 BDD patients. After a variable baseline period of 3-8 weeks participants will start twice weekly with imagery rescripting for 12 sessions, followed by a 6 week follow up. Participants will rate schema- or core beliefs and OCD or BDD severity on a visual analogue scale. In addition participants will rate core emotions, affect and obtrusiveness of the intrusion. Secondary we will asses four times questionnaires about OCD of BDD symptoms, depression and schemas en modes. After treatment participants will be interviewed about their experiences.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Meet the criteria for OCD or BDD, a primary diagnosis according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

• Are aged 18 and beyond

• Dutch literacy

• Cut-off Y-BOCS of 20

• No change in medication. Stable dose at least 6 weeks prior to study.

Locations
Other Locations
Netherlands
Department of Psychiatry, AMC
RECRUITING
Amsterdam-zuidoost
Contact Information
Primary
Tibor van Verseveld
t.r.vanverseveld@amsterdamumc.nl
+31619624228
Backup
Judy Luigjes
j.luigjes@amsterdamumc.nl
Time Frame
Start Date: 2023-04-21
Estimated Completion Date: 2027-01
Participants
Target number of participants: 36
Treatments
Experimental: Imagery Rescripting
Baseline consists of a random assigned period of 3-8 weeks with measurements and no intervention.~Intervention consists of a maximum of 12 sessions of imagery rescripting, provided twice-weekly.~Post treatment follow up consists of 6 weeks with only measurements and no intervention.
Related Therapeutic Areas
Sponsors
Leads: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials